已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Recommendations for the use of DMARDs in pregnancy and reproductive health for patients with rheumatic disease: A scoping review

医学 阿达木单抗 英夫利昔单抗 Golimumab公司 阿巴塔克普 阿纳基纳 依那西普 类风湿性关节炎 托法替尼 内科学 怀孕 托珠单抗 强直性脊柱炎 磺胺吡啶 羟基氯喹 物理疗法 美罗华 重症监护医学 疾病 2019年冠状病毒病(COVID-19) 溃疡性结肠炎 淋巴瘤 传染病(医学专业) 生物 遗传学
作者
Athena Chin,Alice Terrett,Mi‐Hye Kwon,Samuel Whittle,Catherine Hill
出处
期刊:Arthritis Care and Research [Wiley]
标识
DOI:10.1002/acr.25558
摘要

Objective Autoimmune rheumatic diseases commonly affect individuals of childbearing age, with historically increased adverse pregnancy outcomes in this group. The advent of disease‐modifying anti‐rheumatic drugs (DMARDs) has fostered more suitable conditions for pregnancy; however, this is accompanied by challenges in ensuring safe use in reproductive health. The aim of this review is to compare existing guideline recommendations for the use of DMARDs in pregnancy and reproductive health for patients with rheumatic disease. Methods A scoping review was performed with Medline and EMBASE, in addition to a hand search, to identify guidelines published since 2014 by academic societies in rheumatology that addressed management of DMARDs in pregnancy in any of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus. Conventional synthetic DMARDs (csDMARDS; methotrexate, sulfasalazine, leflunomide, hydroxychloroquine), biologic DMARDs (bDMARDs; adalimumab, etanercept, infliximab, golimumab, certolizumab, abatacept, tocilizumab, rituximab, anakinra) and targeted synthetic DMARDs (tsDMARDs; tofacitinib, baricitinib, upadacitinib) were targeted. Two authors performed data extraction in duplicate. Results 18 guidelines were included. Recommendations for DMARD use in pre‐conception were present in 10 (56%), lactation in 12 (67%) and male fertility in 6 (33%). 13 (72%) guidelines included recommendations for csDMARDs, 13 (72%) bDMARDs and 5 (28%) tsDMARDs. There was moderate evidence supporting relatively uniform csDMARD recommendations, compared to minimal evidence for b/tsDMARD use with variable recommendations. Conclusion There is heterogeneity in formulation of guidelines on the use of DMARDs in pregnancy. Recommendations for csDMARDs were similar between guidelines. There was significant variability in recommendations for b/tsDMARD use, reflecting current minimal literature in this area.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Dongbalal完成签到,获得积分10
2秒前
香蕉芙蓉完成签到 ,获得积分10
4秒前
小小旭呀发布了新的文献求助10
5秒前
默默完成签到 ,获得积分10
10秒前
清脆泥猴桃完成签到,获得积分10
12秒前
邪恶土拨鼠完成签到,获得积分10
12秒前
和谐诗双完成签到 ,获得积分10
14秒前
15秒前
大帅比完成签到 ,获得积分10
16秒前
16秒前
17秒前
隐形曼青应助醉熏的幼珊采纳,获得10
18秒前
19秒前
橘子猫发布了新的文献求助10
21秒前
Echo完成签到,获得积分10
21秒前
juan发布了新的文献求助10
22秒前
坦率的从丹完成签到 ,获得积分10
23秒前
jijiguo发布了新的文献求助10
25秒前
shier完成签到 ,获得积分10
25秒前
墨辰完成签到 ,获得积分10
29秒前
qianyixingchen完成签到 ,获得积分10
30秒前
白鸽鸽完成签到,获得积分10
31秒前
小小科学家完成签到 ,获得积分10
31秒前
小枣完成签到 ,获得积分10
32秒前
32秒前
CodeCraft应助jijiguo采纳,获得10
35秒前
Lucas应助jijiguo采纳,获得10
35秒前
Owen应助jijiguo采纳,获得10
35秒前
斯文败类应助jijiguo采纳,获得10
36秒前
冷HorToo完成签到 ,获得积分10
36秒前
Akim应助jijiguo采纳,获得10
36秒前
大个应助jijiguo采纳,获得10
36秒前
Orange应助jijiguo采纳,获得10
36秒前
redstone完成签到,获得积分10
36秒前
G13发布了新的文献求助10
37秒前
细心尔琴完成签到,获得积分10
37秒前
38秒前
135完成签到 ,获得积分10
39秒前
40秒前
41秒前
高分求助中
晶体学对称群—如何读懂和应用国际晶体学表 1500
Constitutional and Administrative Law 1000
Microbially Influenced Corrosion of Materials 500
Die Fliegen der Palaearktischen Region. Familie 64 g: Larvaevorinae (Tachininae). 1975 500
Numerical controlled progressive forming as dieless forming 400
Rural Geographies People, Place and the Countryside 400
Machine Learning for Polymer Informatics 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5385293
求助须知:如何正确求助?哪些是违规求助? 4507902
关于积分的说明 14029231
捐赠科研通 4417843
什么是DOI,文献DOI怎么找? 2426701
邀请新用户注册赠送积分活动 1419398
关于科研通互助平台的介绍 1397838